RecruitingNot ApplicableNCT06457139

Preventing T2DM After GDM With Immediate Postpartum Screening

Preventing Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus With Immediate Postpartum Screening


Sponsor

University of Massachusetts, Worcester

Enrollment

116 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The overall goal of this proposal is to create and test an implementation protocol for in-hospital immediate postpartum diabetes screening for postpartum patients with pregnancies affected by GDM.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria5

  • pregnancy complicated by GDM as diagnosed with traditional two step testing in the third trimester according to Carpenter-Coustan Criteria
  • receiving prenatal care at UMASS Memorial and plans to deliver at UMASS Memorial
  • able and willing to provide informed consent
  • ability to complete immediate in hospital postpartum glucose testing
  • have evidence of impaired glucose metabolism defined as fasting glucose value of ≥126 mg/dL or 2-hour glucose value of ≥200 mg/dL

Exclusion Criteria3

  • known diagnosis of pre-existing pre-gestational diabetes in pregnancy
  • inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test) in pregnancy or immediately postpartum
  • systemic steroid use

Interventions

DIAGNOSTIC_TESTGlucose tolerance test (2 hour)

Early testing with the 2 hour glucose tolerance test will occur during their inpatient postpartum hospitalization.

OTHERActive Comparator

Subjects randomized to the comparison condition will receive the usual standard of care. The standard of care will consist of administration of educational materials adapted from the American Diabetes Association that discusses healthy lifestyle behaviors and the increased risks of developing T2DM after a pregnancy complicated by GDM.


Locations(1)

University of Massachusetts Memorial Medical Center

Worcester, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06457139


Related Trials